ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY REDUCES HBsAg LEVELS IN HBeAg-NEGATIVE, GENOTYPE D CHRONIC HEPATITIS B PATIENTS FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUE TREATMENT: THE HERMES STUDY

被引：6
|
作者：
Lampertico, P. [1 ]
Brunetto, M. R. [2 ]
Craxi, A. [3 ]
Gaeta, G. B. [4 ]
Rizzetto, M. [5 ]
Palmieri, G. [6 ]
Colombo, M. [1 ]
机构：
[1] Univ Milan, Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[2] Univ Hosp Pisa, Liver Unit, Reference Ctr Chron Liver Dis & HCC Tuscany Reg, Pisa, Italy
[3] Univ Palermo, DiBiMIS, Gastroenterol & Hepatol, Palermo, Italy
[4] Univ Naples 2, Sect Infect Dis & Viral Hepatitis, Dept Internal Med, Naples, Italy
[5] Univ Turin, Dept Gastroenterol, Turin, Italy
[6] Roche, Monza, Italy
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30179-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LP25
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 50 条
  • [1] ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY REDUCES HBSAG LEVELS IN HBEAG-NEGATIVE, GENOTYPE D CHRONIC HEPATITIS B PATIENTS FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUES TREATMENT: FINAL RESULTS OF THE HERMES STUDY
    Lampertico, P.
    Brunetto, M. R.
    Craxi, A.
    Gaeta, G. B.
    Rizzetto, M.
    Rozzi, A.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S223 - S223
  • [2] Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in chronic hepatitis B, HBeAg-negative, genotype D patients fully suppressed on nucleot(s)ide analogues treatment: HERMES Study Interim Analysis
    Lampertico, Pietro
    Brunetto, Maurizia R.
    Craxi, Antonio
    Gaeta, Giovanni B.
    Rizzetto, Mario
    Palmieri, Giulio
    Colombo, Massimo
    HEPATOLOGY, 2014, 60 (06) : 1285A - 1286A
  • [3] ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY REDUCES HBSAG LEVELS IN CHRONIC HEPATITIS B, HBEAG-NEGATIVE, GENOTYPE D PATIENTS FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUES TREATMENT: HERMES STUDY INTERIM ANALYSIS
    Lampertico, P.
    Brunetto, M. R.
    Craxi, A.
    Gaeta, G. B.
    Rizzetto, M.
    Palmieri, G.
    Colombo, M.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E28 - E28
  • [4] Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D
    Lampertico, Pietro
    Brunetto, Maurizia R.
    Craxi, Antonio
    Gaeta, Giovanni B.
    Rizzetto, Mario
    Rozzi, Antonella
    Colombo, Massimo
    Antonio, D.
    Andreone, P.
    Antonio, D.
    Brancaccio, G.
    Bronte, F.
    Bruzzone, L.
    Caccamo, G.
    Caccianotti, B.
    Calvaruso, V
    Chessa, L.
    Ciarallo, M.
    Coco, B.
    Colombatto, P.
    Cursaro, C.
    D'Aluisio, D.
    Demelia, L.
    Di Marco, V
    Dissegna, D.
    Invernizzi, F.
    Lenisa, I
    Lembo, T.
    Levrero, M.
    Marchese, V
    Mangia, G.
    Picciotto, A.
    Pierconti, S.
    Antonio, D.
    Raimondo, G.
    Rastelli, C.
    Rizzo, V
    Santantonio, T.
    Scuteri, A.
    Sorbello, O.
    Squadrito, G.
    Subic, M.
    Toniutto, P.
    Vukotic, R.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (01) : 118 - 125
  • [5] Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis
    Boglione, Lucio
    Cariti, Giuseppe
    Ghisetti, Valeria
    Burdino, Elisa
    Di Perri, Giovanni
    JOURNAL OF MEDICAL VIROLOGY, 2018, 90 (06) : 1047 - 1052
  • [6] Early On-Treatment Prediction of Response to Peginterferon Alfa-2a for HBeAg-Negative Chronic Hepatitis B Using HBsAg and HBV DNA Levels
    Rijckborst, Vincent
    Hansen, Bettina E.
    Cakaloglu, Yilmaz
    Ferenci, Peter
    Tabak, Fehmi
    Akdogan, Meral
    Simon, Krzysztof
    Akarca, Ulus S.
    Flisiak, Robert
    Verhey, Elke
    Van Vuuren, Anneke J.
    Boucher, Charles A. B.
    ter Borg, Martijn J.
    Janssen, Harry L. A.
    HEPATOLOGY, 2010, 52 (02) : 454 - 461
  • [7] MAINTENANCE PEGINTERFERON ALFA-2A TREATMENT REDUCES HBSAG LEVEL IN GENOTYPE D HBEAG-NEGATIVE INTERFERON-RESPONDERS (INTERIM RESULTS)
    Krastev, Z.
    Jelev, D.
    Ivanova, A.
    Antonov, K.
    Kosseva, O.
    Kotzev, I.
    Ivanova, I.
    Balabanska, R.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S292 - S292
  • [8] On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients
    Goulis, Ioannis
    Karatapanis, Stylianos
    Akriviadis, Evangelos
    Deutsch, Melanie
    Dalekos, George N.
    Raptopoulou-Gigi, Maria
    Mimidis, Konstantinos
    Germanidis, George
    Drakoulis, Christos
    Triantos, Christos
    Zintzaras, Elias
    Bakalos, Georgios
    Papatheodoridis, George
    LIVER INTERNATIONAL, 2015, 35 (05) : 1540 - 1548
  • [9] Extended Peginterferon Alfa-2a (Pegasys) Therapy in Chinese Patients With HBeAg-Negative Chronic Hepatitis B
    Chen, Xuefu
    Chen, Xiaoping
    Chen, Wenli
    Ma, Xiaojun
    Huang, Jing
    Chen, Ren
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (10) : 1705 - 1713
  • [10] IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B HBSAG SERUM LEVELS EARLY DURING TREATMENT WITH PEGINTERFERON ALFA-2A PREDICT HBSAG CLEARANCE 4 YEARS POST-TREATMENT
    Marcellin, Patrick
    Brunetto, Maurizia
    Bonino, Ferruccio
    Hadziyannis, Stephanos J.
    Kapprell, Hans-Peter
    McCloud, Philip I.
    Batrla, Richard
    HEPATOLOGY, 2008, 48 (04) : 718A - 719A
12345